UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036846
Receipt number R000041976
Scientific Title Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan
Date of disclosure of the study information 2019/05/27
Last modified on 2019/05/24 23:15:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Acronym

Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Scientific Title

Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Scientific Title:Acronym

Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Region

Japan


Condition

Condition

Lung cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the ratio of patients with interstitial lung disease who have received RT for lung cancer, the incidence of acute exacerbation in such patients, and the risk factors for acute exacerbation.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ratio of acute exacerbation

Key secondary outcomes

The ratio of acute exacerbation related death
The ratio of interstitial lung disease on radiation therapy for lung cancer


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Diagnosed as malignant tumor of lung.
Diagnosed as interstitial lung disease.
Case of radiotherapy.

Key exclusion criteria

Patients who have refused to use data.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Nagata

Organization

Hiroshima University

Division name

Radiation Oncology Department

Zip code

734-8551

Address

Kasumi 4-9-1, Minami-ku Hiroshima, Japan

TEL

082-257-1545

Email

nagat@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Yasuhito
Middle name
Last name Hagiwara

Organization

Yamagata University Faculty of Medicine

Division name

Department of Radiation Oncology

Zip code

990-9585

Address

Iidanishi 2-2-2, Yamagata, Japan

TEL

023-628-5386

Homepage URL


Email

hagiwara.yasuhito@gmail.com


Sponsor or person

Institute

Lung and Mediastinal Tumor Committee of Japanese Radiation Oncology Study Group (JROSG)

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanagawa Cancer Center IRB

Address

Nakao 2-3-2, Asahi-ku, Yokohama, Japan

Tel

045-520-2222

Email

chiken-jimu4@kcch.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

67

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 31 Day

Date of IRB

2016 Year 09 Month 08 Day

Anticipated trial start date

2016 Year 09 Month 08 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 05 Month 24 Day

Last modified on

2019 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041976


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name